Next generation of porphysomes for improved photodynamic therapy applications

IF 11.5 1区 医学 Q1 CHEMISTRY, MULTIDISCIPLINARY Journal of Controlled Release Pub Date : 2025-05-10 Epub Date: 2025-03-10 DOI:10.1016/j.jconrel.2025.113621
Jana Alhoussein , Khatia Merabishvili , Tiffany Ho , Abdechakour Elkihel , Paul Cressey , Ágota Tóth , Ashley Qian , Mélanie Hery , Juliette Vergnaud , Séverine Domenichini , Florent Di Meo , Juan Chen , Gang Zheng , Ali Makky
{"title":"Next generation of porphysomes for improved photodynamic therapy applications","authors":"Jana Alhoussein ,&nbsp;Khatia Merabishvili ,&nbsp;Tiffany Ho ,&nbsp;Abdechakour Elkihel ,&nbsp;Paul Cressey ,&nbsp;Ágota Tóth ,&nbsp;Ashley Qian ,&nbsp;Mélanie Hery ,&nbsp;Juliette Vergnaud ,&nbsp;Séverine Domenichini ,&nbsp;Florent Di Meo ,&nbsp;Juan Chen ,&nbsp;Gang Zheng ,&nbsp;Ali Makky","doi":"10.1016/j.jconrel.2025.113621","DOIUrl":null,"url":null,"abstract":"<div><div>Porphysomes are a class of liposome-like nanoparticles that have demonstrated efficacy in photothermal therapy (PTT) and photodynamic therapy (PDT) against cancer. These nanoparticles results from the self-assembly of amphiphilic phospholipid-porphyrin (PL-Por) conjugates. Despite their potential, porphysomes exhibit a high photothermal effect and a weak photodynamic activity as long as they remain intact within the body. In this study, we present the design of a novel generation of smart porphysomes capable of undergoing active dissociation and releasing porphyrin moieties upon illumination, thereby enabling tunable photothermal properties with enhanced photodynamic efficiency. These new porphysomes are composed of smart PL-Por conjugates that exhibit one or two ROS-responsive linkers separating the polar head group from the porphyrin moiety. Among the designed molecules, we demonstrated that monosubstituted conjugates bearing either pyro-a or pheo-a porphyrinoids with one ROS-responsive bond and shorter linker showed the best performance in terms of stability, photothermal and photodynamic efficiencies in vitro. Moreover, these assemblies were found to achieve complete tumor ablation in 80 % of PC3 prostate subcutaneous tumor-bearing mice after 30 days post-PDT, compared to 0 % using conventional porphysomes. Consequently, our strategy enabled the development of a versatile platform for delivering porphyrin-based photosensitizers for enhanced photodynamic applications.</div></div>","PeriodicalId":15450,"journal":{"name":"Journal of Controlled Release","volume":"381 ","pages":"Article 113621"},"PeriodicalIF":11.5000,"publicationDate":"2025-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Controlled Release","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S016836592500238X","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/10 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0

Abstract

Porphysomes are a class of liposome-like nanoparticles that have demonstrated efficacy in photothermal therapy (PTT) and photodynamic therapy (PDT) against cancer. These nanoparticles results from the self-assembly of amphiphilic phospholipid-porphyrin (PL-Por) conjugates. Despite their potential, porphysomes exhibit a high photothermal effect and a weak photodynamic activity as long as they remain intact within the body. In this study, we present the design of a novel generation of smart porphysomes capable of undergoing active dissociation and releasing porphyrin moieties upon illumination, thereby enabling tunable photothermal properties with enhanced photodynamic efficiency. These new porphysomes are composed of smart PL-Por conjugates that exhibit one or two ROS-responsive linkers separating the polar head group from the porphyrin moiety. Among the designed molecules, we demonstrated that monosubstituted conjugates bearing either pyro-a or pheo-a porphyrinoids with one ROS-responsive bond and shorter linker showed the best performance in terms of stability, photothermal and photodynamic efficiencies in vitro. Moreover, these assemblies were found to achieve complete tumor ablation in 80 % of PC3 prostate subcutaneous tumor-bearing mice after 30 days post-PDT, compared to 0 % using conventional porphysomes. Consequently, our strategy enabled the development of a versatile platform for delivering porphyrin-based photosensitizers for enhanced photodynamic applications.

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
下一代卟啉体改善光动力治疗应用
卟啉体是一类脂质体样纳米颗粒,已被证明在光热治疗和光动力治疗中具有抗癌效果。这些纳米颗粒是由两亲性磷脂-卟啉(PL-Por)偶联物的自组装产生的。尽管具有潜力,但只要卟啉体在体内保持完整,就会表现出高光热效应和光动力活性弱。在这项研究中,我们设计了新一代的智能卟啉体,能够在光照下进行主动解离并释放卟啉部分,从而实现可调的光热性能和光动力效率的提高。这些新的卟啉体由聪明的PL-Por偶联物组成,具有一个或两个ros响应连接体,将极性头基团与卟啉部分分开。在设计的分子中,我们证明了带有一个ros响应键和较短连接体的单取代偶联物在体外稳定性、光热和光动力效率方面表现出最好的性能。此外,在pdt后30 天,发现这些组合在80% %的PC3前列腺皮下荷瘤小鼠中实现了完全的肿瘤消融,而使用常规卟体则为0% %。因此,我们的策略能够开发一个多功能平台,用于提供基于卟啉的光敏剂,以增强光动力学应用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Controlled Release
Journal of Controlled Release 医学-化学综合
CiteScore
18.50
自引率
5.60%
发文量
700
审稿时长
39 days
期刊介绍: The Journal of Controlled Release (JCR) proudly serves as the Official Journal of the Controlled Release Society and the Japan Society of Drug Delivery System. Dedicated to the broad field of delivery science and technology, JCR publishes high-quality research articles covering drug delivery systems and all facets of formulations. This includes the physicochemical and biological properties of drugs, design and characterization of dosage forms, release mechanisms, in vivo testing, and formulation research and development across pharmaceutical, diagnostic, agricultural, environmental, cosmetic, and food industries. Priority is given to manuscripts that contribute to the fundamental understanding of principles or demonstrate the advantages of novel technologies in terms of safety and efficacy over current clinical standards. JCR strives to be a leading platform for advancements in delivery science and technology.
期刊最新文献
Near-infrared light-switchable unlocking of tumour-specific prodrug nanosystem for synergistic enhancement of reactive nitrogen species-based therapy Injectable acid-labile thermosensitive magnetic hydrogel with responsive drug release for bridging liver transplantation in hepatocellular carcinoma Lipid droplet-regulated multipathway-induced type I interferon tempest for ferroptosis-immune synergistic therapy of tumors Structure-corona-function engineering of micelles enables rapid hepatic bioactivation of clopidogrel for emergency antiplatelet therapy Multiaspect layered double hydroxide nanohybrid counteracts pathophysiological cascade for ischemic stroke intervention
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1